Ovarian cancer (OvCa) metastasizes to organs in the abdominal cavity, such as the omentum, which are covered by a single layer of mesothelial cells. Mesothelial cells are generally thought to be “bystanders” to the metastatic process and simply displaced by OvCa cells to access the submesothelial extracellular matrix. Here, using organotypic 3D cultures, we found that primary human mesothelial cells secrete fibronectin in the presence of OvCa cells. Moreover, we evaluated the tumor stroma of 108 human omental metastases and determined that fibronectin was consistently overexpressed in these patients. Blocking fibronectin production in primary mesothelial cells in vitro or in murine models, either genetically (fibronectin 1 floxed mouse model) or via siRNA, decreased adhesion, invasion, proliferation, and metastasis of OvCa cells. Using a coculture model, we determined that OvCa cells secrete TGF-β1, which in turn activates a TGF-β receptor/RAC1/SMAD-dependent signaling pathway in the mesothelial cells that promotes a mesenchymal phenotype and transcriptional upregulation of fibronectin. Additionally, blocking α5 or β1 integrin function with antibodies reduced metastasis in an orthotopic preclinical model of OvCa metastasis. These findings indicate that cancer-associated mesothelial cells promote colonization during the initial steps of OvCa metastasis and suggest that mesothelial cells actively contribute to metastasis.
Hilary A. Kenny, Chun-Yi Chiang, Erin A. White, Elizabeth M. Schryver, Mohammed Habis, Iris L. Romero, Andras Ladanyi, Carla V. Penicka, Joshy George, Karl Matlin, Anthony Montag, Kristen Wroblewski, S. Diane Yamada, Andrew P. Mazar, David Bowtell, Ernst Lengyel
Title and authors | Publication | Year |
---|---|---|
The extracellular matrix protein type I collagen and fibronectin are regulated by β-arrestin-1/endothelin axis in human ovarian fibroblasts
Masi I, Ottavi F, Caprara V, Rio DD, Kunkl M, Spadaro F, Licursi V, Tuosto L, Bagnato A, Rosano\u2019 L |
Journal of Experimental & Clinical Cancer Research : CR | 2025 |
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements.
Wang Y, Zhu N, Liu J, Chen F, Song Y, Ma Y, Yang Z, Wang D |
Journal of translational medicine | 2025 |
Interplay of integrins and selectins in metastasis
Maltseva D, Nersisyan A, Tonevitsky A |
Molecular Oncology | 2025 |
Secretory factors from omental preadipocytes support ovarian cancer tumorigenesis via matrix remodeling and IGF signaling
Jennifer Waters, Mikella Robinson, Omar Lujano-Olazaba, Samuel F Gilbert, Carrie House |
Cancer research | 2024 |
HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling
Terri M, Sandoval P, Bontempi G, Montaldo C, Tomero-Sanz H, de Turris V, Trionfetti F, Pascual-Antón L, Clares-Pedrero I, Battistelli C, Valente S, Zwergel C, Mai A, Rosanò L, del Pozo MÁ, Sánchez-Álvarez M, Cabañas C, Tripodi M, López-Cabrera M, Strippoli R |
Journal of experimental & clinical cancer research : CR | 2024 |
Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk
Shea AA, Heffron CL, Grieco JP, Roberts PC, Schmelz EM |
Frontiers in immunology | 2024 |
Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses
Zhang C, Nan X, Zhang B, Wu H, Zeng X, Song Z, Li S, Wang J, Xie S, Zhang G, Xiu H, Wang J, Guo J, Wang P, Cai Z, Zhen Y, Shen Y |
Theranostics | 2024 |
A Recipe for Successful Metastasis: Transition and Migratory Modes of Ovarian Cancer Cells
Śliwa A, Szczerba A, Pięta PP, Białas P, Lorek J, Nowak-Markwitz E, Jankowska A |
Cancers | 2024 |
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching PA, Lambrechts D, García MJ, Rodríguez-Antona C, Goodman MT, Modugno F, Moysich KB, Karlan BY, Lester J, Kjaer SK, Jensen A, Høgdall E, Goode EL, Cliby WA, Kumar A, Wang C, Cunningham JM, Winham SJ, Monteiro AN, Schildkraut JM, Cramer DW, Terry KL, Titus L, Bjorge L, Thomsen LC, Pejovic T, Høgdall CK, McNeish IA, May T, Huntsman DG, Pfisterer J, Canzler U, Park-Simon TW, Schröder W, Belau A, Hanker L, Harter P, Sehouli J, Kimmig R, de Gregorio N, Schmalfeldt B, Baumann K, Hilpert F, Burges A, Winterhoff B, Schürmann P, Speith LM, Hillemanns P, Berchuck A, Johnatty SE, Ramus SJ, Chenevix-Trench G, Pharoah PD, Dörk T, Heitz F |
npj Genomic Medicine | 2024 |
Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination.
Fujimoto H, Yoshihara M, Rodgers R, Iyoshi S, Mogi K, Miyamoto E, Hayakawa S, Hayashi M, Nomura S, Kitami K, Uno K, Sugiyama M, Koya Y, Yamakita Y, Nawa A, Enomoto A, Ricciardelli C, Kajiyama H |
Cancer metastasis reviews | 2024 |
Ovarian tumor cell-derived JAGGED2 promotes omental metastasis through stimulating the Notch signaling pathway in the mesothelial cells.
Islam SS, Al-Mohanna FH, Yousef IM, Al-Badawi IA, Aboussekhra A |
Cell Death and Disease | 2024 |
Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis‐associated adhesion of ovarian cancer cells
Neuhaus F, Lieber S, Shinkevich V, Steitz AM, Raifer H, Roth K, Finkernagel F, Worzfeld T, Burchert A, Keber C, Nist A, Stiewe T, Reinartz S, Beutgen VM, Graumann J, Pauck K, Garn H, Gaida M, Müller R, Huber M |
Clinical and Translational Medicine | 2024 |
The role of Piezo1 mechanotransduction in high-grade serous ovarian cancer: Insights from an in vitro model of collective detachment.
Micek HM, Yang N, Dutta M, Rosenstock L, Ma Y, Hielsberg C, McCord M, Notbohm J, McGregor S, Kreeger PK |
Science Advances | 2024 |
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness
Battistini C, Kenny HA, Zambuto M, Nieddu V, Melocchi V, Decio A, Lo Riso P, Villa CE, Gatto A, Ghioni M, Porta FM, Testa G, Giavazzi R, Colombo N, Bianchi F, Lengyel E, Cavallaro U |
Cell Death and Disease | 2024 |
Enhancing PKA-dependent mesothelial barrier integrity reduces ovarian cancer transmesothelial migration via inhibition of contractility
Jazwinska DE, Cho Y, Zervantonakis IK |
iScience | 2024 |
Exploiting Matrix Stiffness to Overcome Drug Resistance.
Aydin HB, Ozcelikkale A, Acar A |
ACS Biomaterials Science & Engineering | 2024 |
Recent Progress in the Application of Exosome Analysis in Ovarian Cancer Management.
Keyvani V, Ghale-Noie ZN, Mollazadeh S, Mahmoudian RA, Ghorbani E, Naderi H, Khazaei M, Hassanian SM, Ferns GA, Avan A, Anvari K |
Current cancer drug targets | 2024 |
Macrophage diversity in cancer dissemination and metastasis.
Mantovani A, Marchesi F, Di Mitri D, Garlanda C |
Cellular & molecular immunology | 2024 |
Gene Profiling of Circular RNAs in Keloid-prone Individuals and ceRNA Network Construction During Wound Healing.
Yang J, Zhu Z, Xu Y, Xu S, Zhang Y, Liu Z, Liu X, Shi J, Han B |
Aesthetic plastic surgery | 2024 |
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies
Amer H, Kampan NC, Itsiopoulos C, Flanagan KL, Scott CL, Kartikasari AE, Plebanski M |
Cancers | 2024 |
Cancer-Associated Mesothelial Cell-Derived ANGPTL4 Promotes the Early Steps of Ovarian Cancer Metastasis
Preety Bajwa, Kasjusz Kordylewicz, Agnes Bilecz, Ricardo Lastra, Kristen Wroblewski, Yuval Rinkevich, Ernst Lengyel, Hilary Kenny |
JCI Insight | 2023 |
Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments
Battistini C, Cavallaro U |
Cancers | 2023 |
Tumor microenvironment in ovarian cancer peritoneal metastasis
Mei S, Chen X, Wang K, Chen Y |
Cancer Cell International | 2023 |
Mitochondrial plasticity supports proliferative outgrowth and invasion of ovarian cancer spheroids during adhesion
Grieco JP, Compton SL, Bano N, Brookover L, Nichenko AS, Drake JC, Schmelz EM |
Frontiers in Oncology | 2023 |
Macrophages Promote Ovarian Cancer-Mesothelial Cell Adhesion by Upregulation of ITGA2 and VEGFC in Mesothelial Cells
Cho SK, Lee K, Woo JH, Choi JH |
Cells | 2023 |
Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes
Micek HM, Rosenstock L, Ma Y, Hielsberg C, Montemorano L, Gari MK, Ponik SM, Kreeger PK |
2023 | |
Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems.
Tomas E, Shepherd TG |
Journal of Ovarian Research | 2023 |
Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance.
Nairuz T, Mahmud Z, Manik RK, Kabir Y |
Stem Cell Reviews and Reports | 2023 |
Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity
Miyamoto T, Murphy B, Zhang N |
Frontiers in immunology | 2023 |
Role of Exosomes in the Invasion and Metastasis of Ovarian Cancer and Application Potential of Clinical Diagnosis and Treatment
Zhu Y, Wang C, Ma Z, Li F, Xu C, Pan W, Liu A |
Journal of Cancer | 2023 |
TMTC1 promotes invasiveness of ovarian cancer cells through integrins β1 and β4.
Yeh TC, Lin NY, Chiu CY, Hsu TW, Wu HY, Lin HY, Chen CH, Huang MC |
Cancer Gene Therapy | 2023 |
Cancer cell‐derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression through fibronectin
Koizume S, Kanayama T, Kimura Y, Hirano H, Takahashi T, Ota Y, Miyazaki K, Yoshihara M, Nakamura Y, Yokose T, Kato H, Takenaka K, Sato S, Tadokoro H, Miyagi E, Miyagi Y |
Cancer Science | 2023 |
“DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
Wilczyński JR, Wilczyński M, Paradowska E |
Frontiers in Oncology | 2023 |
Fibronectin contributes to a BRAF inhibitor-driven invasive phenotype in thyroid cancer through EGR1, which can be blocked by inhibition of ERK1/2.
Hicks HM, Pozdeyev N, Sams SB, Pugazhenthi U, Bales ES, Hofmann MC, McKenna LR, Schweppe RE |
Molecular cancer research : MCR | 2023 |
Regional Immunotherapy for Peritoneal Carcinomatosis in Gastroesophageal Cancer: Emerging Strategies to Re-Condition a Maladaptive Tumor Environment
Lewis CR, Dadgar N, Yellin SA, Donnenberg VS, Donnenberg AD, Bartlett DL, Allen CJ, Wagner PL |
Cancers | 2023 |
Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment
Jazwinska DE, Kulawiec DG, Zervantonakis IK |
AJP Cell Physiology | 2023 |
Revisiting the Use of Normal Saline for Peritoneal Washing in Ovarian Cancer
Akasaka H, Naora H |
International journal of molecular sciences | 2023 |
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer
Dondi A, Lischetti U, Jacob F, Singer F, Borgsmüller N, Coelho R, Heinzelmann-Schwarz V, Beisel C, Beerenwinkel N |
Nature Communications | 2023 |
DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression.
Akinjiyan FA, Ibitoye Z, Zhao P, Shriver LP, Patti GJ, Longmore GD, Fuh KC |
Oncogene | 2023 |
Adipocyte Microenvironment in Ovarian Cancer: A Critical Contributor?
Duarte Mendes A, Freitas AR, Vicente R, Vitorino M, Vaz Batista M, Silva M, Braga S |
International journal of molecular sciences | 2023 |
Ovarian cancer relies on the PDGFRβ–fibronectin axis for tumorsphere formation and metastatic spread
Gendrau\u2010Sanclemente N, Figueras A, Gracova K, Lahiguera Á, Alsina\u2010Sanchís E, Marín\u2010Jiménez JA, Vidal A, Matias\u2010Guiu X, Fernandez\u2010Gonzalez S, Barahona M, Martí L, Ponce J, Viñals F |
Molecular Oncology | 2023 |
Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins
Schab AM, Greenwade MM, Stock E, Lomonosova E, Cho K, Grither WR, Noia H, Wilke D, Mullen MM, Hagemann AR, Hagemann IS, Thaker PH, Kuroki LM, McCourt CK, Khabele D, Powell MA, Mutch DG, Zhao P, Shriver LP, Patti GJ, Longmore GD, Fuh KC |
Molecular cancer research : MCR | 2023 |
Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells
S Capellero, J Erriquez, C Battistini, R Porporato, G Scotto, F Borella, M Renzo, G Valabrega, M Olivero |
International journal of molecular sciences | 2022 |
MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial–mesenchymal transition (MMT) of human peritoneal mesothelial cells
Y Kimura, H Ohzawa, H Miyato, Y Kaneko, A Saito, K Takahashi, M Tojo, H Yamaguchi, K Kurashina, S Saito, Y Hosoya, A Lefor, N Sata, J Kitayama |
Scientific Reports | 2022 |
Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy
X Huang, M Qiu, T Wang, B Li, S Zhang, T Zhang, P Liu, Q Wang, Z Qian, C Zhu, M Wu, J Zhao |
Journal of nanobiotechnology | 2022 |
Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine
C Yee, K Dickson, M Muntasir, Y Ma, D Marsh |
Frontiers in Bioengineering and Biotechnology | 2022 |
Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
J Wilczyński, M Wilczyński, E Paradowska |
International journal of molecular sciences | 2022 |
The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer
J Mikuła-Pietrasik, S Rutecki, K Książek |
Cellular and Molecular Life Sciences | 2022 |
Polymeric Hydrogels for In Vitro 3D Ovarian Cancer Modeling
S Braccini, C Tacchini, F Chiellini, D Puppi |
International journal of molecular sciences | 2022 |
Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
J Clark, C Fotopoulou, P Cunnea, J Krell |
Frontiers in Oncology | 2022 |
Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis
L Chen, R Huang, P Su, L Chu, Y Weng, H Wang, H Lai, K Wen |
International journal of molecular sciences | 2022 |
Ovulation Enhances Intraperitoneal and Ovarian Seedings of High-Grade Serous Carcinoma Cells Originating from the Fallopian Tube: Confirmation in a Bursa-Free Mouse Xenograft Model
Hsu CF, Seenan V, Wang LY, Chu TY |
International journal of molecular sciences | 2022 |
The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination
Ritch SJ, Telleria CM |
Frontiers in Endocrinology | 2022 |
Quantitative biophysical metrics for rapid evaluation of ovarian cancer metastatic potential
Mukherjee A, Zhang H, Ladner K, Brown M, Urbanski J, Grieco JP, Kapania RK, Lou E, Behkam B, Schmelz EM, Nain AS |
Molecular biology of the cell | 2022 |
DDR2 Expression in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Tumor Invasion and Metastasis through Periostin-ITGB1
Akinjiyan FA, Dave RM, Alpert E, Longmore GD, Fuh KC |
Cancers | 2022 |
Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancer
Condello S, Prasad M, Atwani R, Matei D |
The Journal of biological chemistry | 2022 |
Pigment epithelium-derived factor promotes peritoneal dissemination of ovarian cancer through induction of immunosuppressive macrophages.
Ueno S, Sudo T, Saya H, Sugihara E |
2022 | |
Alpha-Mangostin Reduces Pericellular Fibronectin on Suspended Tumor Cells and Therapeutically, but Not Prophylactically, Suppresses Distant Metastasis
Huang LT, Kuo CH, Tseng L, Li YS, Cheng LH, Cheng CY, Sheu SR, Chang WT, Chen CC, Cheng HC |
Life Sciences | 2022 |
Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.
Carigga Gutierrez NM, Pujol-Solé N, Arifi Q, Coll JL, le Clainche T, Broekgaarden M |
Cancer metastasis reviews | 2022 |
Polarity switching of ovarian cancer cell clusters via SRC family kinase is involved in the peritoneal dissemination
Kawata M, Kondo J, Onuma K, Ito Y, Yokoi T, Hamanishi J, Mandai M, Kimura T, Inoue M |
Cancer Science | 2022 |
The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
Zheng A, Wei Y, Zhao Y, Zhang T, Ma X |
Frontiers in immunology | 2022 |
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells.
Lennartz M, Atug D, Dwertmann Rico S, Reiswich V, Viehweger F, Büscheck F, Kluth M, Hube-Magg C, Hinsch A, Bernreuther C, Sauter G, Burandt E, Marx AH, Krech T, Simon R, Minner S, Clauditz TS, Jacobsen F, Lebok P, Gorbokon N, Möller K, Steurer S, Fraune C |
2022 | |
Laminins in tumor-derived exosomes upregulated by ETS1 reprogram omental macrophages to promote omental metastasis of ovarian cancer
Li H, Zeng C, Shu C, Cao Y, Shao W, Zhang M, Cao H, Zhao S |
Cell Death and Disease | 2022 |
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary
Doberstein K, Spivak R, Reavis HD, Hooda J, Feng Y, Kroeger PT Jr, Stuckelberger S, Mills GB, Devins KM, Schwartz LE, Iwanicki MP, Fogel M, Altevogt P, Drapkin R |
Communications biology | 2022 |
PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome
Salvi A, Hardy LR, Heath KN, Watry S, Pergande MR, Cologna SM, Burdette JE |
Neoplasia (New York, N.Y.) | 2022 |
Cancer associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling
Jin Qian, Bauer L. LeSavage, Kelsea M. Hubka, Chenkai Ma, Suchitra Natarajan, Joshua T Eggold, Yiren Xiao, Katherine C Fuh, Venkatesh Krishnan, Annika Enejder, Sarah Heilshorn, Oliver Dorigo, Erinn B. Rankin |
Journal of Clinical Investigation | 2021 |
Modelling TGFβR and Hh pathway regulation of prognostic matrisome molecules in ovarian cancer
RM Delaine-Smith, E Maniati, B Malacrida, S Nichols, R Roozitalab, RR Jones, LS Lecker, OM Pearce, MM Knight, FR Balkwill |
iScience | 2021 |
The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis
MI Umar, W Hassan, G Murtaza, M Buabeid, E Arafa, HM Irfan, MZ Asmawi, X Huang |
Pathology oncology research : POR | 2021 |
Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
M Terri, F Trionfetti, C Montaldo, M Cordani, M Tripodi, M Lopez-Cabrera, R Strippoli |
Frontiers in immunology | 2021 |
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
EA Pietilä, J Gonzalez-Molina, L Moyano-Galceran, S Jamalzadeh, K Zhang, L Lehtinen, SP Turunen, TA Martins, O Gultekin, T Lamminen, K Kaipio, U Joneborg, J Hynninen, S Hietanen, S Grénman, R Lehtonen, S Hautaniemi, O Carpén, JW Carlson, K Lehti |
Nature Communications | 2021 |
TGFβ signaling networks in ovarian cancer progression and plasticity
A Kumari, Z Shonibare, M Monavarian, RC Arend, NY Lee, GJ Inman, K Mythreye |
Clinical & Experimental Metastasis | 2021 |
Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer
A Ghoneum, S Almousa, B Warren, AY Abdulfattah, J Shu, H Abouelfadl, D Gonzalez, C Livingston, N Said |
Seminars in Cancer Biology | 2021 |
Personalized Models of Heterogenous 3D Epithelial Tumor Microenvironments: Ovarian Cancer as a Model
E Horst, M Bregenzer, P Mehta, C Snyder, T Repetto, Y Yang-Hartwich, G Mehta |
Acta Biomaterialia | 2021 |
Topological defects in the mesothelium suppress ovarian cancer cell clearance
J Zhang, N Yang, PK Kreeger, J Notbohm |
2021 | |
Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis
DD Rio, I Masi, V Caprara, F Spadaro, F Ottavi, R Strippoli, P Sandoval, M López-Cabrera, RS de la Cuesta, A Bagnato, L Rosanò |
Frontiers in Cell and Developmental Biology | 2021 |
Ovarian Cancer-Associated Mesothelial Cells: Transdifferentiation to Minions of Cancer and Orchestrate Developing Peritoneal Dissemination
K Mogi, M Yoshihara, S Iyoshi, K Kitami, K Uno, S Tano, Y Koya, M Sugiyama, Y Yamakita, A Nawa, H Tomita, H Kajiyama |
Cancers | 2021 |
Characterization of TGFβ-associated molecular features and drug responses in gastrointestinal adenocarcinoma
Q Zhang, F Liu, L Qin, Z Liao, J Song, H Liang, X Chen, Z Zhang, B Zhang |
BMC Gastroenterology | 2021 |
Small extracellular vesicles from malignant ascites of patients with advanced ovarian cancer provide insights into the dynamics of the extracellular matrix
B Bortot, M Apollonio, E Rampazzo, F Valle, M Brucale, A Ridolfi, B Ura, R Addobbati, GD Lorenzo, F Romano, F Buonomo, C Ripepi, G Ricci, S Biffi |
Molecular Oncology | 2021 |
Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
L Pascual-Antón, B Cardeñes, RS de la Cuesta, L González-Cortijo, M López-Cabrera, C Cabañas, P Sandoval |
International journal of molecular sciences | 2021 |
The Natural Product β-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis
HA Kenny, PC Hart, K Kordylewicz, M Lal, M Shen, B Kara, YJ Chen, N Grassl, Y Alharbi, BR Pattnaik, KM Watters, MS Patankar, M Ferrer, E Lengyel |
Cancers | 2021 |
Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts
P Uruski, J Mikuła-Pietrasik, M Pakuła, S Budkiewicz, M Drzewiecki, AN Gaiday, M Wierzowiecka, E Naumowicz, R Moszyński, A Tykarski, K Książek |
International journal of molecular sciences | 2021 |
Ovarian-Cancer-Associated Extracellular Vesicles: Microenvironmental Regulation and Potential Clinical Applications
PK Croft, S Sharma, N Godbole, GE Rice, C Salomon |
Cells | 2021 |
Aberrant Methylation and Immune Microenvironment Are Associated With Overexpressed Fibronectin 1: A Diagnostic and Prognostic Target in Head and Neck Squamous Cell Carcinoma
S Sheng, B Guo, Z Wang, Z Zhang, J Zhou, Z Huo |
Frontiers in Molecular Biosciences | 2021 |
Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers
MS Krishnan, AR KD, J Park, V Arjunan, FJ Marques, A Bermudez, OA Girvan, NS Hoang, J Yin, MH Nguyen, N Kothary, S Pitteri, DW Felsher, R Dhanasekaran |
Hepatology | 2021 |
The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination
S Serratì, L Porcelli, F Fragassi, M Garofoli, RD Fonte, L Fucci, RM Iacobazzi, A Palazzo, F Margheri, G Cristiani, A Albano, RD Luca, DF Altomare, M Simone, A Azzariti |
Cancers | 2021 |
Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer
Y Zhang, YJ Wei, YF Zhang, HW Liu, YF Zhang |
Frontiers in Oncology | 2021 |
The multicellular signalling network of ovarian cancer metastases
L Sommerfeld, F Finkernagel, JM Jansen, U Wagner, A Nist, T Stiewe, S MüllerBrüsselbach, AM Sokol, J Graumann, S Reinartz, R Müller |
Clinical and Translational Medicine | 2021 |
Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
TS Hilliard, B Kowalski, K Iwamoto, EA Agadi, Y Liu, J Yang, M Asem, Y Klymenko, J Johnson, Z Shi, G Marfowaa, MG Yemc, P Petrasko, MS Stack |
International journal of molecular sciences | 2021 |
Modeling the Tumor Microenvironment of Ovarian Cancer: The Application of Self-Assembling Biomaterials
AK Mendoza-Martinez, D Loessner, A Mata, HS Azevedo |
Cancers | 2021 |
Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK
X Liang, J Ju |
Oncology reports | 2021 |
Ovarian Cancer: Methods and Protocols
PK Kreeger |
2021 | |
Ovarian Cancer: Methods and Protocols
PK Kreeger |
2021 | |
HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies
X Wang, Z Du, T Xu, X Wang, W Li, J Gao, J Li, H Zhu |
Frontiers in Oncology | 2021 |
Amelioration of human peritoneal mesothelial cell co-culture-evoked malignant potential of ovarian cancer cells by acacetin involves LPA release-activated RAGE-PI3K/AKT signaling
M Tian, Y Tang, T Huang, Y Liu, Y Pan |
Cellular & Molecular Biology Letters | 2021 |
Effects of integrin-linked kinase on protein kinase b, glycogen synthase kinase-3β, and β-catenin molecules in ovarian cancer cells
Seda Mehtap Sarı Kılıçaslan, Zerrin İncesu |
Iranian Journal of Basic Medical Sciences | 2021 |
Fibroblast subtypes define a metastatic matrisome in breast cancer
Heather M. Brechbuhl, Alexander S. Barrett, Etana Kopin, Jaime C. Hagen, Amy L. Han, Austin E. Gillen, Jessica Finlay-Schultz, Diana M. Cittelly, Philip Owens, Kathryn B. Horwitz, Carol A. Sartorius, Kirk C. Hansen, Peter Kabos |
JCI Insight | 2020 |
A Novel Role for NUAK1 in Promoting Ovarian Cancer Metastasis through Regulation of Fibronectin Production in Spheroids
JL Fritz, O Collins, P Saxena, A Buensuceso, YR Valdes, KE Francis, KR Brown, B Larsen, K Colwill, AC Gingras, R Rottapel, TG Shepherd |
Cancers | 2020 |
Shaping Up the Tumor Microenvironment With Cellular Fibronectin
G Efthymiou, A Saint, M Ruff, Z Rekad, D Ciais, EV Obberghen-Schilling |
Frontiers in Oncology | 2020 |
Molecular mediators of peritoneal metastasis in pancreatic cancer
LR Avula, B Hagerty, C Alewine |
Cancer and Metastasis Reviews | 2020 |
The influence of secreted factors and extracellular vesicles in ovarian cancer metastasis
M Hergueta-Redondo, H Peinado |
European Journal of Cancer Supplements | 2020 |
Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1
V Krishnan, S Tallapragada, B Schaar, K Kamat, AM Chanana, Y Zhang, S Patel, V Parkash, C Rinker-Schaeffer, AK Folkins, EB Rankin, O Dorigo |
2020 | |
Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis
YL Huang, CY Liang, D Ritz, R Coelho, D Septiadi, M Estermann, C Cumin, N Rimmer, A Schötzau, MN López, A Fedier, M Konantz, T Vlajnic, D Calabrese, C Lengerke, L David, B Rothen-Rutishauser, F Jacob, V Heinzelmann-Schwarz |
eLife | 2020 |
Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin
RM Brandão-Costa, E Helal-Neto, AM Vieira, P Barcellos-de-Souza, J Morgado-Diaz, C Barja-Fidalgo |
International journal of molecular sciences | 2020 |
The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis
K Noh, DH Bach, HJ Choi, MS Kim, SY Wu, S Pradeep, C Ivan, MS Cho, E Bayraktar, C Rodriguez-Aguayo, SK Dasari, E Stur, LS Mangala, G Lopez-Berestein, AK Sood |
Oncogene | 2020 |
Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes
SN Thomas, B Friedrich, M Schnaubelt, DW Chan, H Zhang, R Aebersold |
iScience | 2020 |
Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
KA Kujawa, E Zembala-Nożyńska, AJ Cortez, T Kujawa, J Kupryjańczyk, KM Lisowska |
Cells | 2020 |
Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer
L Alonso-Alconada, A de la Fuente, M Santacana, A Ferreiros, R Lopez-Lopez, X Matias-Guiu, M Abal |
Disease models & mechanisms | 2020 |
Role of Epithelial–Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments
ML Calabrò, N Lazzari, G Rigotto, M Tonello, A Sommariva |
International journal of molecular sciences | 2020 |
Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
JD Hebert, SA Myers, A Naba, G Abbruzzese, JM Lamar, SA Carr, RO Hynes |
Cancer research | 2020 |
Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma
HF Berg, Z Ju, M Myrvold, KE Fasmer, MK Halle, EA Hoivik, SN Westin, J Trovik, IS Haldorsen, GB Mills, C Krakstad, HM Werner |
British Journal of Cancer | 2020 |
Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion
M Estermann, YL Huang, D Septiadi, D Ritz, CY Liang, F Jacob, B Drasler, A Petri-Fink, V Heinzelmann-Schwarz, B Rothen-Rutishauser, S Ahmad |
PloS one | 2020 |
PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling
MK Siu, Y Jiang, J Wang, TH Leung, SF Ngu, AN Cheung, HY Ngan, KK Chan |
Oncogenesis | 2020 |
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion
K Ojasalu, C Brehm, K Hartung, M Nischak, F Finkernagel, P Rexin, A Nist, E Pavlakis, T Stiewe, JM Jansen, U Wagner, S Gattenlöhner, A Bräuninger, S MüllerBrüsselbach, S Reinartz, R Müller |
Molecular Oncology | 2020 |
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer
PC Hart, T Chiyoda, X Liu, M Weigert, M Curtis, CY Chiang, R Loth, R Lastra, SM McGregor, JW Locasale, E Lengyel, IL Romero |
Molecular cancer research : MCR | 2019 |
Current progress in the inflammatory background of angiogenesis in gynecological cancers
G Szewczyk, TM Maciejewski, D Szukiewicz |
Inflammation Research | 2019 |
Ovarian Cancer Dissemination—A Cell Biologist’s Perspective
S Farsinejad, T Cattabiani, T Muranen, M Iwanicki |
Cancers | 2019 |
Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target
K Nakamura, K Sawada, M Kobayashi, M Miyamoto, A Shimizu, M Yamamoto, Y Kinose, T Kimura |
Cancers | 2019 |
Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis
Aziz, Agarwal, Dasari, Mitra |
Cancers | 2019 |
Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis
HA Kenny, M Lal-Nag, M Shen, B Kara, DA Nahotko, K Wroblewski, S Fazal, S Chen, CY Chiang, YJ Chen, KR Brimacombe, J Marugan, M Ferrer, E Lengyel |
Molecular cancer therapeutics | 2019 |
Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
PC Hart, HA Kenny, N Grassl, KM Watters, LM Litchfield, F Coscia, I Blaženović, L Ploetzky, O Fiehn, M Mann, E Lengyel, IL Romero |
Cell Reports | 2019 |
Ovarian cancer‐associated mesothelial cells induce acquired platinum‐resistance in peritoneal metastasis via the FN1/Akt signaling pathway
M Yoshihara, H Kajiyama, A Yokoi, M Sugiyama, Y Koya, Y Yamakita, W Liu, K Nakamura, Y Moriyama, H Yasui, S Suzuki, Y Yamamoto, C Ricciardelli, A Nawa, K Shibata, F Kikkawa |
International Journal of Cancer | 2019 |
Fibrin Deposit on the Peritoneal Surface Serves as a Niche for Cancer Expansion in Carcinomatosis Patients
S Shahid, A Iman, U Matti, K Rachid, A Assaf, C Eveno, P Marc, M Massoud |
Neoplasia (New York, N.Y.) | 2019 |
Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis
S Natarajan, KM Foreman, MI Soriano, NS Rossen, H Shehade, DR Fregoso, JT Eggold, V Krishnan, O Dorigo, AJ Krieg, SC Heilshorn, S Sinha, KC Fuh, EB Rankin |
Cancer research | 2019 |
Metastasis Organotropism: Redefining the Congenial Soil
Y Gao, I Bado, H Wang, W Zhang, JM Rosen, XH Zhang |
Developmental Cell | 2019 |
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
Q Gao, Z Yang, S Xu, X Li, X Yang, P Jin, Y Liu, X Zhou, T Zhang, C Gong, X Wei, D Liu, C Sun, G Chen, J Hu, L Meng, J Zhou, K Sawada, R Fruscio, TW Grunt, J Wischhusen, VM Vargas-Hernández, B Pothuri, RL Coleman |
Journal of Experimental Medicine | 2019 |
Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6
A Chryplewicz, SM Tienda, DA Nahotko, PN Peters, E Lengyel, MA Eckert |
Scientific Reports | 2019 |
Fibronectin in Cancer: Friend or Foe
TC Lin, CH Yang, LH Cheng, WT Chang, YR Lin, HC Cheng |
Cells | 2019 |
Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis
S McGuire, B Kara, PC Hart, A Montag, K Wroblewski, S Fazal, XY Huang, E Lengyel, HA Kenny |
Gynecologic Oncology | 2019 |
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts
MA Eckert, F Coscia, A Chryplewicz, JW Chang, KM Hernandez, S Pan, SM Tienda, DA Nahotko, G Li, I Blaženović, RR Lastra, M Curtis, SD Yamada, R Perets, SM McGregor, J Andrade, O Fiehn, RE Moellering, M Mann, E Lengyel |
Nature | 2019 |
Therapeutic Targeting of Collective Invasion in Ovarian Cancer
L Moffitt, N Karimnia, A Stephens, M Bilandzic |
International journal of molecular sciences | 2019 |
Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells
M Pakuła, A Witucka, P Uruski, A Radziemski, R Moszyński, D Szpurek, K Maksin, A Woźniak, S Sajdak, A Tykarski, J Mikuła-Pietrasik, K Książek |
Scientific Reports | 2019 |
Presence and role of stem cells in ovarian cancer
NK Suster, I Virant-Klun |
World journal of stem cells | 2019 |
An omentum-inspired 3D PEG hydrogel for identifying ECM-drivers of drug resistant ovarian cancer
EA Brooks, MF Gencoglu, DC Corbett, KR Stevens, SR Peyton |
2019 | |
Fibronectin in malignancy: Cancer-specific alterations, protumoral effects, and therapeutic implications
JW Rick, A Chandra, CD Ore, AT Nguyen, G Yagnik, MK Aghi |
Seminars in Oncology | 2019 |
A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages
MB Buechler, KW Kim, EJ Onufer, JW Williams, CC Little, CX Dominguez, Q Li, W Sandoval, JE Cooper, CA Harris, MR Junttila, GJ Randolph, SJ Turley |
Immunity | 2019 |
Transcriptome Profiling Reveals Matrisome Alteration as a Key Feature of Ovarian Cancer Progression
S Mitra, K Tiwari, R Podicheti, T Pandhiri, DB Rusch, A Bonetto, C Zhang, AK Mitra |
Cancers | 2019 |
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma
F Nigim, J Kiyokawa, A Gurtner, Y Kawamura, L Hua, EM Kasper, PK Brastianos, DP Cahill, SD Rabkin, RL Martuza, WS Carbonell, H Wakimoto |
Targeted Oncology | 2019 |
Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study
JM Nie, HF Li |
Experimental and therapeutic medicine | 2018 |
Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression
S Dasari, Y Fang, AK Mitra |
Cancers | 2018 |
Charting the unexplored extracellular matrix in cancer
EC Filipe, JL Chitty, TR Cox |
International Journal of Experimental Pathology | 2018 |
The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation
AJ McKenzie, SR Hicks, KV Svec, H Naughton, ZL Edmunds, AK Howe |
Scientific Reports | 2018 |
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis
M Curtis, HA Kenny, B Ashcroft, A Mukherjee, A Johnson, Y Zhang, Y Helou, R Batlle, X Liu, N Gutierrez, X Gao, SD Yamada, R Lastra, A Montag, N Ahsan, JW Locasale, AR Salomon, AR Nebreda, E Lengyel |
Cell Metabolism | 2018 |
Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities
A Ghoneum, H Afify, Z Salih, M Kelly, N Said |
Cancer Medicine | 2018 |
Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment
KM Watters, P Bajwa, HA Kenny |
Cancers | 2018 |
Role of tumor microenvironment in ovarian cancer pathobiology
A Ghoneum, H Afify, Z Salih, M Kelly, N Said |
Oncotarget | 2018 |
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
A Ladanyi, A Mukherjee, HA Kenny, A Johnson, AK Mitra, S Sundaresan, KM Nieman, G Pascual, SA Benitah, A Montag, SD Yamada, NA Abumrad, E Lengyel |
Oncogene | 2018 |
Mechanisms and context underlying the role of autophagy in cancer metastasis
CM Dower, CA Wills, SM Frisch, HG Wang |
Autophagy | 2018 |
Recent advances in understanding the complexities of metastasis
JL Chitty, EC Filipe, MC Lucas, D Herrmann, TR Cox, P Timpson |
F1000Research | 2018 |
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
N Nwani, L Sima, W Nieves-Neira, D Matei |
Cancers | 2018 |
ADH1B promotes mesothelial clearance and ovarian cancer infiltration
KM Gharpure, OD Lara, Y Wen, S Pradeep, C LaFargue, C Ivan, R Rupaimoole, W Hu, LS Mangala, SY Wu, AS Nagaraja, K Baggerly, AK Sood |
Oncotarget | 2018 |
The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
T Hilliard |
Cancers | 2018 |
FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer
H Lai, X Zhao, Y Qin, Y Ding, R Chen, G Li, M Labrie, Z Ding, J Zhou, J Hu, D Ma, Y Fang, Q Gao |
Journal of Experimental & Clinical Cancer Research | 2018 |
Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition
Q Li, B Li, Q Li, S Wei, Z He, X Huang, L Wang, Y Xia, Z Xu, Z Li, W Wang, L Yang, D Zhang, Z Xu |
Cell Death and Disease | 2018 |
Characterization of the PEGylated Functional Upstream Domain Peptide (PEG-FUD): a Potent Fibronectin Assembly Inhibitor with Potential as an Anti-Fibrotic Therapeutic
P Zbyszynski, BR Tomasini-Johansson, DM Peters, GS Kwon |
Pharmaceutical Research | 2018 |
Knockdown of Heparanase Suppresses Invasion of Human Trophoblasts by Activating p38 MAPK Signaling Pathway
G Che, Y Wang, B Zhou, L Gao, T Wang, F Yuan, L Zhang |
Disease Markers | 2018 |
Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase
L Hudson, J Gillette, H Kang, M Rivera, A Wandinger-Ness |
Cancers | 2018 |
Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells
A Yoshimura, K Sawada, K Nakamura, Y Kinose, E Nakatsuka, M Kobayashi, M Miyamoto, K Ishida, Y Matsumoto, M Kodama, K Hashimoto, S Mabuchi, T Kimura |
BMC Cancer | 2018 |
Unraveling the Journey of Cancer Stem Cells from Origin to Metastasis
RK Nimmakayala, SK Batra, MP Ponnusamy |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 2018 |
Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma
M Barbolina |
Cancers | 2018 |
Fibronectin Regulates the Dynamic Formation of Ovarian Cancer Multicellular Aggregates and the Expression of Integrin Receptors
Lin Gong, Ying Zheng, Shanling Liu, Zhilan Peng |
Asian Pacific Journal of Cancer Prevention | 2018 |
Fibrosis of mesothelial cell-induced peritoneal implantation of ovarian cancer cells
J Wang, C Liu, X Chang, Y Qi, Z Zhu, X Yang |
Cancer management and research | 2018 |
A Proximal Culture Method to Study Paracrine Signaling Between Cells
S Dasari, T Pandhiri, J Haley, D Lenz, AK Mitra |
Journal of visualized experiments : JoVE | 2018 |
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
T Worzfeld, EP von Strandmann, M Huber, T Adhikary, U Wagner, S Reinartz, R Müller |
Frontiers in Oncology | 2017 |
Ovarian and Breast Cancer Migration Dynamics on Laminin and Fibronectin Bi-directional Gradient Fibers Fabricated via Multiphoton Excited Photochemistry
V Ajeti, J Lara-Santiago, S Alkmin, PJ Campagnola |
Cellular and Molecular Bioengineering | 2017 |
The peritoneal “soil” for a cancerous “seed”: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases
J Mikuła-Pietrasik, P Uruski, A Tykarski, K Książek |
Cellular and Molecular Life Sciences | 2017 |
TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells
W Li, X Zhang, J Wang, M Li, C Cao, J Tan, D Ma, Q Gao |
Oncotarget | 2017 |
Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O2 and Plasma Supply
S Koizume, Y Miyagi |
International journal of molecular sciences | 2017 |
A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR
TS Lau, LK Chan, EC Wong, CW Hui, K Sneddon, TH Cheung, SF Yim, JH Lee, CS Yeung, TK Chung, J Kwong |
Oncogene | 2017 |
Ovarian cancer stem cells: still an elusive entity?
M Lupia, U Cavallaro |
Molecular Cancer | 2017 |
Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer: Mesothelial-to-mesenchymal transition and peritoneal metastatic niche
A Rynne-Vidal, CL Au-Yeung, JA Jiménez-Heffernan, ML Pérez-Lozano, L Cremades-Jimeno, C Bárcena, I Cristóbal-García, C Fernández-Chacón, TL Yeung, SC Mok, P Sandoval, M López-Cabrera |
The Journal of Pathology | 2017 |
A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth
M Lal-Nag, L McGee, R Guha, E Lengyel, HA Kenny, M Ferrer |
SLAS Discovery | 2017 |
Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
JP Wang, A Hielscher |
Journal of Cancer | 2017 |
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis
S Xia, C Wang, EL Postma, Y Yang, X Ni, W Zhan |
OncoTargets and therapy | 2017 |
Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review
JO van Baal, CJ van Noorden, R Nieuwland, KK de Vijver, A Sturk, WJ van Driel, GG Kenter, CA Lok |
Journal of Histochemistry & Cytochemistry | 2017 |
Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
SS Li, CK Ip, MY Tang, SK Sy, S Yung, TM Chan, M Yang, HC Shum, AS Wong |
Journal of visualized experiments : JoVE | 2017 |
Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
OM Pearce, RM Delaine-Smith, E Maniati, S Nichols, J Wang, S Böhm, V Rajeeve, D Ullah, P Chakravarty, RR Jones, A Montfort, T Dowe, J Gribben, JL Jones, HM Kocher, JS Serody, BG Vincent, J Connelly, JD Brenton, C Chelala, PR Cutillas, M Lockley, C Bessant, MM Knight, FR Balkwill |
Cancer Discovery | 2017 |
Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review.
Kobayashi M, Sawada K, Kimura T |
Cancers | 2017 |
Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones
YA Ren, LK Mullany, Z Liu, AJ Herron, KK Wong, JS Richards |
Cancer research | 2016 |
Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer
PG Moon, JE Lee, YE Cho, SJ Lee, YS Chae, JH Jung, IS Kim, HY Park, MC Baek |
Oncotarget | 2016 |
Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells
F Roggiani, D Mezzanzanica, K Rea, A Tomassetti |
International journal of molecular sciences | 2016 |
Fibrotic microenvironment promotes the metastatic seeding of tumor cells via activating the fibronectin 1/secreted phosphoprotein 1-integrin signaling
C Zhang, M Wu, L Zhang, LR Shang, JH Fang, SM Zhuang |
Oncotarget | 2016 |
The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration
I Lua, K Asahina |
Gut and Liver | 2016 |
Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status
F Coscia, KM Watters, M Curtis, MA Eckert, CY Chiang, S Tyanova, A Montag, RR Lastra, E Lengyel, M Mann |
Nature Communications | 2016 |
The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate
KL Boylan, PC Buchanan, RD Manion, DM Shukla, K Braumberger, C Bruggemeyer, AP Skubitz |
Oncotarget | 2016 |
Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells
J Mikuła-Pietrasik, P Uruski, K Matuszkiewicz, S Szubert, R Moszyński, D Szpurek, S Sajdak, A Tykarski, K Książek |
Cellular Oncology | 2016 |
Cooperative effects of fibronectin matrix assembly and initial cell–substrate adhesion strength in cellular self-assembly
JR Brennan, DC Hocking |
Acta Biomaterialia | 2016 |
Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases
J Mikuła-Pietrasik, P Uruski, P Sosińska, K Maksin, H Piotrowska-Kempisty, M Kucińska, M Murias, S Szubert, A Woźniak, D Szpurek, S Sajdak, K Piwocka, A Tykarski, K Książek |
Cell Death and Disease | 2016 |
Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform
Y Zhang, SK Sriraman, HA Kenny, E Luther, V Torchilin, E Lengyel |
Molecular cancer therapeutics | 2016 |
Diverse properties of the mesothelial cells in health and disease
K Kawanishi |
Pleura and Peritoneum | 2016 |
Mechanisms and Targets Involved in Dissemination of Ovarian Cancer
H. WEIDLE U, BIRZELE F, KOLLMORGEN G, RUEGER R |
Cancer genomics & proteomics | 2016 |
The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
A Cho, VM Howell, EK Colvin |
Frontiers in Oncology | 2015 |
EMT-Inducing Molecular Factors in Gynecological Cancers
L Campo, C Zhang, EK Breuer |
BioMed Research International | 2015 |
Pathophysiological role of microRNA-29 in pancreatic cancer stroma
JJ Kwon, SC Nabinger, Z Vega, SS Sahu, RK Alluri, Z Abdul-Sater, Z Yu, J Gore, G Nalepa, R Saxena, M Korc, J Kota |
Scientific Reports | 2015 |
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy
HA Kenny, M Lal-Nag, EA White, M Shen, CY Chiang, AK Mitra, Y Zhang, M Curtis, EM Schryver, S Bettis, A Jadhav, MB Boxer, Z Li, M Ferrer, E Lengyel |
Nature Communications | 2015 |
Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment
IL Romero, A Mukherjee, HA Kenny, LM Litchfield, E Lengyel |
Clinical cancer research | 2015 |
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
TL Yeung, CS Leung, KP Yip, CL Yeung, ST Wong, SC Mok |
American journal of physiology. Cell physiology | 2015 |
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis
A Rynne-Vidal, J Jiménez-Heffernan, C Fernández-Chacón, M López-Cabrera, P Sandoval |
Cancers | 2015 |
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
PN Peters, EM Schryver, E Lengyel, H Kenny |
Journal of visualized experiments : JoVE | 2015 |
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis
AK Mitra, CY Chiang, P Tiwari, S Tomar, KM Watters, ME Peter, E Lengyel |
Oncogene | 2015 |
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast, V Beral, JS Berek, MJ Birrer, S Blagden, MA Bookman, JD Brenton, KB Chiappinelli, FC Martins, G Coukos, R Drapkin, R Edmondson, C Fotopoulou, H Gabra, J Galon, C Gourley, V Heong, DG Huntsman, M Iwanicki, BY Karlan, A Kaye, E Lengyel, DA Levine, KH Lu, IA McNeish, U Menon, SA Narod, BH Nelson, KP Nephew, P Pharoah, DJ Powell, P Ramos, IL Romero, CL Scott, AK Sood, EA Stronach, FR Balkwill |
Nature Reviews Cancer | 2015 |
Role of EGFR expression levels in the regulation of integrin function by EGF: EGFR LEVELS REGULATE INTEGRIN ACTIVATION
D Vial, PJ McKeown-Longo |
Molecular Carcinogenesis | 2015 |
Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer
Beach JA, Aspuria PJ, Cheon DJ, Lawrenson K, Agadjanian H, Walsh CS, Karlan BY, Orsulic S |
Oncotarget | 2015 |
Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism
E Torchiaro, A Lorenzato, M Olivero, D Valdembri, PA Gagliardi, M Gai, J Erriquez, G Serini, MF di Renzo |
Oncotarget | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |